The latest closing stock price for Apellis Pharmaceuticals as of February 21, 2025 is 27.52.
An investor who bought $1,000 worth of Apellis Pharmaceuticals stock at the IPO in 2017 would have $962 today, roughly 1 times their original investment - a 10.10% compound annual growth rate over 7 years.
The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023.
The Apellis Pharmaceuticals 52-week high stock price is 71.90, which is 161.3% above the current share price.
The Apellis Pharmaceuticals 52-week low stock price is 24.34, which is 11.6% below the current share price.
The average Apellis Pharmaceuticals stock price for the last 52 weeks is 38.57.
An investor who bought $1,000 worth of Apellis Pharmaceuticals stock at the IPO in 2017 would have $962 today, roughly 1 times their original investment - a 10.10% compound annual growth rate over 7 years.
The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023.
The Apellis Pharmaceuticals 52-week high stock price is 71.90, which is 161.3% above the current share price.
The Apellis Pharmaceuticals 52-week low stock price is 24.34, which is 11.6% below the current share price.
The average Apellis Pharmaceuticals stock price for the last 52 weeks is 38.57.